Literature DB >> 3607285

An inhibitory monoclonal antibody against human tissue factor.

S D Carson, S E Ross, R Bach, A Guha.   

Abstract

We obtained a hybridoma using immune spleen cells from a mouse injected with human brain tissue factor that had been purified on a factor VII-agarose affinity column. This monoclonal IgG1, HTF1-7B8, inhibits tissue factor procoagulant activity. The concentration of HTF1-7B8 producing half-maximal inhibition is influenced by the concentration of factor VIIa, suggesting that the antibody and enzyme compete for the cofactor. The antibody was successfully used to detect both human and bovine tissue factor on nitrocellulose dot blots, indicating that the epitope recognized by this antibody is conserved in both species. This antibody clearly reveals tissue factor on a Western blot. An HTF1-7B8 affinity column was used to purify tissue factor from both human brain and placenta. The electrophoretic mobilities in polyacrylamide gels in the presence of sodium dodecyl sulfate (SDS) and the amino acid compositions of the purified tissue factor from brain and placenta are indistinguishable, as are their specific procoagulant activities in reconstituted systems. This antibody will be useful for immunopurification and characterization of tissue factor structure and mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607285

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  P-selectin induces the expression of tissue factor on monocytes.

Authors:  A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

2.  Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.

Authors:  M M Aleman; C Gardiner; P Harrison; A S Wolberg
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

3.  Glomerular procoagulant activity in human proliferative glomerulonephritis.

Authors:  P G Tipping; J P Dowling; S R Holdsworth
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.

Authors:  K M Brinkhous; U Hedner; J B Garris; V Diness; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Blood-borne tissue factor: another view of thrombosis.

Authors:  P L Giesen; U Rauch; B Bohrmann; D Kling; M Roqué; J T Fallon; J J Badimon; J Himber; M A Riederer; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

7.  Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

Authors:  D Kirchhofer; T B Tschopp; P Hadváry; H R Baumgartner
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Tissue factor antigen in senile plaques of Alzheimer's disease.

Authors:  R D McComb; K A Miller; S D Carson
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

9.  Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice.

Authors:  J-G Wang; D Manly; D Kirchhofer; R Pawlinski; N Mackman
Journal:  J Thromb Haemost       Date:  2009-04-27       Impact factor: 5.824

10.  Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Authors:  Veronique Ollivier; Jianguo Wang; David Manly; Kellie R Machlus; Alisa S Wolberg; Martine Jandrot-Perrus; Nigel Mackman
Journal:  Thromb Res       Date:  2009-04-05       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.